Clik here to view.
Episode #11: Contemporary approaches to coronary revascularization with Dr...
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #12: Relationships with industry and conflict of interest with Dr Rob...
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #13: RE-LY and PLATO: Direct from ESC Congress 2009 with Ph Gabriel Steg
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #14: International collaboration and mentorship with Paul Armstrong
Dr Paul Armstrong joins the show to discuss the related subjects of international collaboration in research and mentorship amongst physicians.
View ArticleClik here to view.
Episode #15: Care of advanced heart failure patients with Joe Rogers
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #16: PLATO, ticagrelor, and platelet inhibition: Insight from Lars...
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #17: Diabetes and cardiovascular disease with Darren McGuire
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #18: Get With the Guidelines for heart failure with Ileana PiƱa
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #19: Managing acute coronary syndromes in NSTEMI patients with Shamir...
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #20: Clopidogrel and proton-pump inhibitors with Deepak Bhatt
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #21: Global chronic disease research: Learning from India and Kenya...
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #22: Business and practice implications of healthcare reform with...
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #23: FDA advisory committee meetings and the drug-approval process...
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #24: When is a test appropriate to identify obstructive CAD? Dr...
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #25: Platelet responsiveness to antiplatelet therapy with Dr Paul Gurbel
Dr Robert Harrington (Arthur L Bloomfield Professor and chair of the department of medicine at Stanford University) conducts a series of interviews with cardiology leaders for perspectives on the...
View ArticleClik here to view.
Episode #26: Dissecting the controversy around JUPITER with Dr Paul Ridker
Hailed as a landmark trial by many, JUPITER has spawned a vociferous cadre of detractors whose assertions have stirred debate and some controversy throughout the cardiovascular community. Dr Paul...
View ArticleClik here to view.
Episode #27: Elinogrel and INNOVATE PCI with Dr Sunil Rao
From the European Society of Cardiology 2010 Congress, Dr Sunil Rao gives an overview of the field of antiplatelet therapy, reviews the key features of elinogrel, and discusses the design, features,...
View ArticleClik here to view.
Episode #28: AVERROES: Apixaban as a future alternative to warfarin with Dr...
The findings of the AVERROES trial foretell a future with appropriate treatment for patients with atrial fibrillation who are not candidates for anticoagulation with oral vitamin-K antagonists.
View ArticleClik here to view.
Episode #29: Obesity in America with Dr Thad Waites
According to the Center of Disease Control, 72.5 million Americans are obese (with a body-mass index [BMI] >30), and 27% of the increase in healthcare costs is related to the treatment of obesity....
View ArticleClik here to view.
#30: Canadian antiplatelet guidelines with Dr Alan Bell
Notable for their therapy-based approach, rigor, and clarity, the Canadian Cardiovascular Society (CCS) antiplatelet guidelines were recently presented by coauthors Drs Alan Bell and Jean-FranƧois...
View ArticleClik here to view.
#31: Atkins, diet, obesity, and cardiovascular disease risk with Dr Eric Westman
Atkins, diet, obesity, and cardiovascular disease risk with Dr Eric Westman. Hotly debated among healthcare professionals, "low-carb" dietsāsuch as Atkinsāhave soared in popularity, offering...
View ArticleClik here to view.
#32: Advances in heart-failure research with Dr Clyde Yancy
Advances in heart-failure research with Dr Clyde Yancy. Heart-failure is estimated to account for two million hospital admissions per year in the US, based on primary and secondary diagnosis.
View ArticleClik here to view.
#33: Quality assurance in cardiology with Dr John Rumsfeld
Quality assuranceāor appropriate use of cardiology proceduresāis a hot topic that defies simple quantification and has important ramifications for patients, healthcare professionals, and society...
View ArticleClik here to view.
#34: Healthcare reform update: Clinical and business implications for...
Where does healthcare reform stand, and what are the implications for cardiologists? Physician and business leader Dr Kevin Schulman joins the show to help clarify the healthcare debate and shine light...
View ArticleClik here to view.
#35: Oral antithrombotic agents: An update for the clinical practitioner with...
After decades of reliance on warfarin, there are finally new options for oral anticoagulation, with exciting results from the RE-LY, ROCKET, and AVERROES trials paving the way for dabigatran,...
View ArticleClik here to view.
#36: Antiplatelet responsiveness and personalized medicine: Lessons from...
Antiplatelet responsiveness and personalized medicine: Lessons from GRAVITAS and TRIGGER-PCI with Dr Gregg Stone
View ArticleClik here to view.
#37: Reversible anticoagulation in RADAR with Dr Thomas Povsic
Reversible anticoagulation may open the door to more efficacious treatment and better outcomes in settings such as PCI and valve replacement, as well as bypass surgery. But how does the risk of...
View ArticleClik here to view.
#38: HDL cholesterol, niacin, and AIM-HIGH with Dr Jim Stein
Is the concept of raising HDL cholesterol still pertinent in an era of well-controlled LDL levels via statin therapy? To address this question, our guest Dr Jim Stein reviews what evidence exists to...
View ArticleClik here to view.
#39: The uptake of clinical trial findings: Focus on OAT with Dr David Kandzari
Recent reports indicate that the Occluded Arteries Trial (OAT)āwhile continuing to stir debateāhas made little impact on clinical practice among US physicians. What explains this situation?
View ArticleClik here to view.
#40: The civility of professional discourse with Dr Clyde Yancy
With the multiplication of methods of communication, the democratization of access to information, and the fast pace of today's technology it's hard not to feel that professional discourse has taken a...
View ArticleClik here to view.
#41: The ISCHEMIA trial on optimal care for patients with stable coronary...
The large ISCHEMIA trial, led by Dr Judith Hochman, seeks to build on the results of COURAGE and BARI 2D to answer the important question: what is the best treatment for patients with stable coronary...
View ArticleClik here to view.
#42: Statins--Cardiovascular benefit vs diabetes risk with Dr Michael Cobble
Statins have become a cornerstone therapy in the prevention of cardiovascular disease by helping to modify the risk profile of millions of people. But what about a possible connection between statin...
View ArticleClik here to view.
#43: Same-day discharge from the hospital after elective PCI with Dr Sunil Rao
What is the best way to care for patients following PCI? Is same-day discharge a viableāor even desirableāoption? Dr Sunil Rao joins the show to discuss his recent paper in JAMA, including the...
View ArticleClik here to view.
#44: Improving patient adherence to medication with Dr Eric Peterson
Patient adherence to medication has long defied quantification, with many physicians assuming that the cost of medications is the primary factor explaining poor rates of compliance. How do we explain...
View ArticleClik here to view.
#45: Clopidogrel pharmacogenomics: Challenges, controversies, and clinical...
Clopidogrel pharmacogenomics: Challenges, controversies, and clinical implications with Dr Jessica Mega
View ArticleClik here to view.
#46: Healthcare reform and cardiovascular practice in the election year with...
Where do things stand with healthcare reform? What is the status of CMS innovation centers, accountable care models (ACOs), and new models for reimbursement?
View ArticleClik here to view.
#47: Rebooting the medical system with Dr Eric Topol
Technology is the key to a radical transformation of medicine, which is shifting from a population-based model to one of individualization. Will cardiologists and medical practitioners be left behind?
View ArticleClik here to view.
#48: Focus on novel anticoagulants in clinical practice with Dr Elaine Hylek
Cardiologists now have a wealth of choice for anticoagulation, but with competitors to warfarin crowding the physician's office, it's increasingly difficult to select the most appropriate agent for...
View ArticleClik here to view.
#49: The pros and cons of being a cardiologist in 2012 with Dr Seth Bilazarian
Private practitioner and theheart.org blogger Dr Seth Bilazarian joins the show to discuss the pros and cons of cardiology in 2012 and express what continues to make his practice enjoyable and...
View ArticleClik here to view.
#50: Biomarkers: Past, present, future with Dr Jim Januzzi
Biomarkers: Past, present, future with Dr Jim Januzzi
View ArticleClik here to view.
#51: Stem-cell therapy in cardiovascular medicine: An update with Dr Bobby...
Regenerative therapy using stem cells hasāfor a long timeāshown great potential to impact cardiovascular medicine. What's the current state of the field?
View ArticleClik here to view.
#52: Patient adherence and drug discontinuation with Dr Niteesh Choudhry
A combination of many issuesāsuch as misunderstanding the importance of medications, forgetfulness, finances, and more complex social factorsāpatient nonadherence to drug therapy is a major public...
View ArticleClik here to view.
#53: Beta blockers in stable heart disease with Dr Sripal Bangalore
Despite cautious and limited guideline endorsement, beta blockers are widely used in cardiovascular disease (and beyond). Why? Our guest Dr Sripal Bangalore discusses his research, which caused a stir...
View ArticleClik here to view.
#54: Current state of surgical revascularization in patients with CAD with Dr...
The FREEDOM trial has added a wealth of data to the debate on revascularization in patients with heart disease. Dr Timothy Gardner joins the show to discuss the revascularization options, what we have...
View ArticleClik here to view.
#55: Practicing humanism in medicine with Dr Abraham Verghese
Renowned author and internist Dr Abraham Verghese joins Dr Bob Harrington to consider the role of humanism in medical practice and the joy of sharing effective tools for patient care. We can cure...
View ArticleClik here to view.
#56: Talking fat with Dr Roger Blumenthal
With an ever-growing percentage of the population either overweight or obese, the topic of staying trim is a matter of international proportions.
View ArticleClik here to view.
#57: Incentivizing adherence with Drs Steve Driver and Don Hensrud
Patient adherence-as recently demonstrated in the MI FREE trial-is a notoriously complicated issue that is the focus of several ongoing research projects. Drs Steve Driver and Don Hensrud join the show...
View ArticleClik here to view.
Reacting to unanticipated results: A lesson in TACT
Few trials have stirred our imagination--and kept online forums as busy--as the TACT trial. With this controversial study as a backdrop, Drs Bob Harrington and Daniel Mark address the complicated issue...
View ArticleClik here to view.
Training the clinical trialist of tomorrow
Dr Renato Lopes joins Dr Bob Harrington to discuss the recent publication of Understanding Clinical Research and their years mentoring investigators.
View ArticleClik here to view.
Ensuring the validity of published clinical research
The veracity of clinical research has come under fire from varying anglesāfrom concerns of bias from associations such as the Cochrane group, to the widespread outcry caused by the periodic discovery...
View Article
